Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PGC | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
mRNA | NCDN | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
mRNA | ARSA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | DGKD | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | FOXL2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | ZNF706 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
mRNA | GYG1 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
mRNA | CLEC3B | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
mRNA | MXD1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | CSTA | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |